Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Immuno-Oncology Drugs Market Grown from 2024 to 2025?#_x000D_

Over the past few years, there has been a significant surge in the market size for immuno-oncology drugs. Projected to rise from $94.16 billion in 2024 to $106.92 billion in 2025, this market shows a compound annual growth rate (CAGR) of 13.6%. Several factors contribute to this growth during the historic period. These include an increase in the number of cancer cases, solid economic advancement in emerging markets, escalated spending in healthcare, and an upturn in expenditure for pharmaceutical R&D._x000D_

_x000D_

#What Growth Rate Is Anticipated for the Immuno-Oncology Drugs Market in the Coming Years?#_x000D_

In the coming years, the market size for immuno-oncology drugs is predicted to experience substantial growth, reaching $153.16 billion in 2029 with a 9.4% compound annual growth rate (CAGR). This growth during the forecast period can be credited to the escalating investments in immuno-oncology, an increased emphasis on immunotherapy drugs for cancer treatments, and product advancements. Key trends for the forecast period encompass investing in the development of personalized oncology drugs tailored for individual patients, focusing on creating next-generation biologics, prioritizing the development of antibody-drug conjugates, investing in AI solutions to cut R&D expenses and save development time. Additionally, the implementation of immune-oncology combination therapies and car-t therapies are poised to enhance innovation and establish leadership in this category._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3455&type=smp_x000D_

_x000D_

#Who Are the Leading Companies in the Immuno-Oncology Drugs Market?#_x000D_

Major companies operating in the immuno-oncology drugs market include F. Hoffmann-La Roche Ltd., Merck & Co., Bristol-Myers Squibb Company, Amgen Inc, Johnson & Johnson, AstraZeneca Plc, Eli Lilly and Company, Novartis International AG, Pfizer Inc., Sanofi S.A., Arlak Biotech, Apikos Pharma, Kolaz biotech, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Takeda Pharmaceuticals, Astellas Pharma Inc, Otsuka Pharmaceutical Co, Ltd, Legend Biotech Co, Zai Lab, Daiichi Pharmaceutical and Sankyo, AQVIDA GmbH, Baxter International Inc., GlaxoSmithKline plc, Affimed Therapeutics, Autolus Therapeutics, Cellectis, Celyad, GammaDelta Therapeutics, Immunocore, European Medical Center (EMC), Yauza Medical Center, Celon Pharma, Veropharm, Biocad, Selvita, OncoArendi Therapeutics Mabion, Fate Therapeutics, Forty-Seven, Arcus Biosciences, Gritstone Oncology, Rakuten Medical, Rubius Therapeutics, Allogene Therapeutics, Celgene Corporation, Bayer AG, Incyte Corporation, Recepta Biopharma, CSC Pharmaceuticals International, Blanver EN, Sandoz Brazil, Life Pharma, Julphar, NewBridge Pharmaceuticals, Eurolab_x000D_

_x000D_

#What Are the Key Drivers of the Immuno-Oncology Drugs Market?#_x000D_

The global increase in cancer cases is expected to fuel the expansion of the market for immuno-oncology drugs. For example, the American Cancer Society stated in January 2022 that the US is predicted to see 1.9 million new cancer diagnoses and approximately 609,360 deaths due to cancer in this year—about 1,670 deaths each day. Lung, prostate, bowel, and female breast cancer are the four most prevalent types of cancer around the world, comprising 43% of all fresh cancer cases. Consequently, the escalating rates of cancer incidence worldwide are projected to augment the demand for immuno-oncology drugs in the foreseeable future._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3455&type=smp_x000D_

_x000D_

#What Are the Key Market Segments in the Immuno-Oncology Drugs Industry?#_x000D_

The immuno-oncology drugs market covered in this report is segmented –_x000D_

_x000D_

1) By Type: Immune Checkpoint Inhibitors, Immune System Modulators, Other Monoclonal Antibodies, Cancer Vaccines, Others_x000D_

2) By Therapeutic Application: Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Therapeutic Application_x000D_

3) By End-Users: Hospitals, Clinics, Ambulatory Surgical Centers, Others_x000D_

_x000D_

Subsegments:_x000D_

1) By Immune Checkpoint Inhibitors: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors_x000D_

2) By Immune System Modulators: Cytokines, Interferons, Colony-Stimulating Factors_x000D_

3) By Other Monoclonal Antibodies: Targeted Monoclonal Antibodies, Bispecific Antibodies_x000D_

4) By Cancer Vaccines: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines_x000D_

5) By Others: Adoptive Cell Transfer Therapies, Oncolytic Virus Therapies_x000D_

_x000D_

#What Are the Latest Trends in the Immuno-Oncology Drugs Market?#_x000D_

In the immuno-oncology drugs market, leading companies are working together to advance and market a unique checkpoint antibody, which would increase the efficacy of cancer therapy. Constructive cooperation promotes innovation by encouraging interdisciplinary knowledge sharing, accelerating the production of combination therapies, personalized medications, and innovative drug delivery systems. For instance, in March 2023, BioNTech SE, based in Germany, formed an alliance with OncoC4 Inc, a pharmaceutical firm from the US, to jointly advance and market a checkpoint antibody, specifically the anti-CTLA-4 monoclonal antibody candidate termed as ONC-392. This collaboration aims to expand the range of cancer treatment alternatives for multiple solid tumor types._x000D_

_x000D_

#Access The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/immuno-oncology-drug-global-market-report_x000D_

_x000D_

#What Are the Key Regional Markets in the Immuno-Oncology Drugs Industry?#_x000D_

North America was the largest region in the immuno-oncology drugs market in 2024. The regions covered in the immuno-oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Purchase The Full Report Today:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3455_x000D_

_x000D_

#This Report Delivers Insight On: #_x000D_

1. How big is the immuno-oncology drugs market, and how is it changing globally?_x000D_

2. Who are the major companies in the immuno-oncology drugs market, and how are they performing?_x000D_

3. What are the key opportunities and risks in the immuno-oncology drugs market right now?_x000D_

4. Which products or customer segments are growing the most in the immuno-oncology drugs market?_x000D_

5. What factors are helping or slowing down the growth of the immuno-oncology drugs market?_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 2071930708_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model